1. Home
  2. COOK vs PYXS Comparison

COOK vs PYXS Comparison

Compare COOK & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

HOLD

Current Price

$33.66

Market Cap

83.7M

ML Signal

HOLD

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

HOLD

Current Price

$1.70

Market Cap

82.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COOK
PYXS
Founded
1985
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.7M
82.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
COOK
PYXS
Price
$33.66
$1.70
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$53.00
$7.00
AVG Volume (30 Days)
97.6K
335.1K
Earning Date
04-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.03
EPS
N/A
N/A
Revenue
$559,520,000.00
$13,858,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.07
$7,043.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$0.89
52 Week High
$35.56
$5.55

Technical Indicators

Market Signals
Indicator
COOK
PYXS
Relative Strength Index (RSI) 72.74 62.40
Support Level $0.92 $1.28
Resistance Level $35.56 $2.17
Average True Range (ATR) 2.54 0.11
MACD -0.39 0.04
Stochastic Oscillator 82.05 75.00

Price Performance

Historical Comparison
COOK
PYXS

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: